CXCR4 and glioblastoma: The incorporation of CXCR4 led to specific chemotaxis to CXCL12/SDF-1α-expressing GBM U87MG cells, in addition to significantly increasing the survival and even leading to complete remission of tumor xenografts in mice, in comparison to CAR-NK cells without CXCR4 co-expression.